APA (7th ed.) Citation

L, D., C, Q., V, B., H, J., L, M., & D, I. (2026). The Role of Endoscopic Bariatric Treatments in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease. Journal of clinical gastroenterology, 60(5), 394. https://doi.org/10.1097/MCG.0000000000002291

Chicago Style (17th ed.) Citation

L, Dawit, Quon C, Bachu V, Jumo H, Micalo L, and Issa D. "The Role of Endoscopic Bariatric Treatments in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease." Journal of Clinical Gastroenterology 60, no. 5 (2026): 394. https://doi.org/10.1097/MCG.0000000000002291.

MLA (9th ed.) Citation

L, Dawit, et al. "The Role of Endoscopic Bariatric Treatments in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease." Journal of Clinical Gastroenterology, vol. 60, no. 5, 2026, p. 394, https://doi.org/10.1097/MCG.0000000000002291.